USD 2.19
(6.31%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 40.35 Million USD | 3.58% |
2022 | 38.95 Million USD | 33.4% |
2021 | 29.2 Million USD | -8.1% |
2020 | 31.77 Million USD | 10.03% |
2019 | 28.87 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 22.05 Million USD | -10.95% |
2024 Q1 | 24.77 Million USD | -38.61% |
2023 FY | 40.35 Million USD | 3.58% |
2023 Q3 | 40.31 Million USD | -0.36% |
2023 Q2 | 40.46 Million USD | -0.35% |
2023 Q1 | 40.6 Million USD | 4.24% |
2023 Q4 | 40.35 Million USD | 0.08% |
2022 Q3 | 38.7 Million USD | 33.32% |
2022 Q2 | 29.03 Million USD | -0.1% |
2022 Q1 | 29.06 Million USD | -0.48% |
2022 FY | 38.95 Million USD | 33.4% |
2022 Q4 | 38.95 Million USD | 0.65% |
2021 Q4 | 29.2 Million USD | -0.25% |
2021 FY | 29.2 Million USD | -8.1% |
2021 Q3 | 29.27 Million USD | -8.13% |
2021 Q2 | 31.86 Million USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 31.77 Million USD | 10.03% |
2020 Q4 | 31.77 Million USD | 0.0% |
2019 FY | 28.87 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 99.746% |
Allurion Technologies Inc. | 41.85 Million USD | 3.598% |
Artivion, Inc. | 359.34 Million USD | 88.771% |
Avanos Medical, Inc. | 209.1 Million USD | 80.703% |
Butterfly Network, Inc. | 25.02 Million USD | -61.23% |
Butterfly Network, Inc. | 25.02 Million USD | -61.23% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 97.13% |
Boston Scientific Corporation | 9.49 Billion USD | 99.575% |
Perspective Therapeutics, Inc. | - USD | -Infinity% |
CONMED Corporation | 991.25 Million USD | 95.929% |
Edwards Lifesciences Corporation | 694.9 Million USD | 94.193% |
Paragon 28, Inc. | 112.03 Million USD | 63.982% |
Glaukos Corporation | 383.73 Million USD | 89.485% |
Globus Medical, Inc. | 520.4 Million USD | 92.246% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -62.404% |
Integer Holdings Corporation | 1.04 Billion USD | 96.124% |
Medtronic plc | 26.04 Billion USD | 99.845% |
Nevro Corp. | 221.82 Million USD | 81.81% |
Owlet, Inc. | 15.21 Million USD | -165.188% |
Penumbra, Inc. | 234.34 Million USD | 82.781% |
Vicarious Surgical Inc. | 14.83 Million USD | -172.054% |
Smith & Nephew plc | 3.08 Billion USD | 98.692% |
STERIS plc | 3.38 Billion USD | 98.807% |
Stryker Corporation | 12.99 Billion USD | 99.689% |
Vapotherm, Inc. | 112.39 Million USD | 64.098% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 99.327% |